×
About 231,448 results

ALLMedicine™ Lung Cancer Center

Research & Reviews  107,037 results

Influence of bilateral mediastinal lymph node dissection on survival in non-small cell ...
https://doi.org/10.1016/j.lungcan.2021.04.018
Lung Cancer (Amsterdam, Netherlands); Kużdżał J, Trybalski Ł et. al.

May 8th, 2021 - This study aimed to analyze the effect of bilateral mediastinal lymphadenectomy (BML) on survival of non-small cell lung cancer (NSCLC) patients. The hypothesis was: BML offers survival benefit as compared with SLND. A randomized clinical trial in...

Tumor mutational burden assessment in non-small-cell lung cancer samples: results from ...
https://doi.org/10.1136/jitc-2020-001904
Journal for Immunotherapy of Cancer; Ramos-Paradas J, Hernández-Prieto S et. al.

May 8th, 2021 - Tumor mutational burden (TMB) is a recently proposed predictive biomarker for immunotherapy in solid tumors, including non-small cell lung cancer (NSCLC). Available assays for TMB determination differ in horizontal coverage, gene content and algor...

Attention to the Principles of Exercise Training in Exercise Studies of Persons With Lu...
https://doi.org/10.1123/japa.2020-0269
Journal of Aging and Physical Activity; Medysky ME, Bland KA et. al.

May 8th, 2021 - The authors systematically reviewed and summarized exercise trials in persons with lung cancer on (a) attention to the principles of exercise training (specificity, progression, overload, initial values, reversibility, and diminishing returns); (b...

Blood lead levels and lung cancer mortality: An updated analysis of NHANES II and III.
https://doi.org/10.1002/cam4.3943
Cancer Medicine; Rhee J, Graubard BI et. al.

May 8th, 2021 - Previous analyses within the National Health and Nutrition Examination Survey (NHANES) II and III cycles suggested an association between blood lead levels (BLLs) and lung cancer mortality, although the evidence was limited by small case numbers. ...

see more →

Guidelines  653 results

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and ...
https://doi.org/10.1016/j.annonc.2021.03.207
Annals of Oncology : Official Journal of the European Soc... Dingemans AC, Früh M et. al.

Apr 17th, 2021 - Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.|2021|Dingemans AC,Früh M,Ardizzoni A,Besse B,Faivre-Finn C,|

Staged management of cardiac disease and concomitant early lung cancer: a 20-year single-center experience
https://pubmed.ncbi.nlm.nih.gov/33210113/
European Journal of Cardio-Thoracic Surgery; Tricard J

Apr 12th, 2021 - The association of unstable heart disease and resectable lung cancer is rare. The impacts of staged management, cardiac surgery with cardiopulmonary bypass (CPB) versus angioplasty, on long-term survival and cancer recurrence remain debated. We re...

Sensations, symptoms, and then what? Early bodily experiences prior to diagnosis of lung cancer
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0249114
PLoS One; Bernhardson BM

Mar 28th, 2021 - Lung cancer (LC) generally lacks unique core symptoms or signs. However, there are a multitude of bodily sensations that are often non-specific, not easily understood, and many times initially not recognized as indicative of LC by the affected per...

The Aging Lung: Physiology, disease, and immunity
https://pubmed.ncbi.nlm.nih.gov/33811810/
Cell Schneider JL

Mar 25th, 2021 - The population is aging at a rate never seen before in human history. As the number of elderly adults grows, it is imperative we expand our understanding of the underpinnings of aging biology. Human lungs are composed of a unique panoply of cell t...

Prophylactic cranial irradiation for extensive‐stage small cell lung cancer
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014559/full
Cochrane Database of Systematic Reviews; Nishie K

Mar 17th, 2021 - To assess the effectiveness and safety of PCI plus standard treatment compared to standard treatment alone in people with ED‐SCLC who have responded to first‐line chemotherapy.

see more →

Drugs  381 results see all →

Clinicaltrials.gov  115,995 results

Influence of bilateral mediastinal lymph node dissection on survival in non-small cell ...
https://doi.org/10.1016/j.lungcan.2021.04.018
Lung Cancer (Amsterdam, Netherlands); Kużdżał J, Trybalski Ł et. al.

May 8th, 2021 - This study aimed to analyze the effect of bilateral mediastinal lymphadenectomy (BML) on survival of non-small cell lung cancer (NSCLC) patients. The hypothesis was: BML offers survival benefit as compared with SLND. A randomized clinical trial in...

Tumor mutational burden assessment in non-small-cell lung cancer samples: results from ...
https://doi.org/10.1136/jitc-2020-001904
Journal for Immunotherapy of Cancer; Ramos-Paradas J, Hernández-Prieto S et. al.

May 8th, 2021 - Tumor mutational burden (TMB) is a recently proposed predictive biomarker for immunotherapy in solid tumors, including non-small cell lung cancer (NSCLC). Available assays for TMB determination differ in horizontal coverage, gene content and algor...

Attention to the Principles of Exercise Training in Exercise Studies of Persons With Lu...
https://doi.org/10.1123/japa.2020-0269
Journal of Aging and Physical Activity; Medysky ME, Bland KA et. al.

May 8th, 2021 - The authors systematically reviewed and summarized exercise trials in persons with lung cancer on (a) attention to the principles of exercise training (specificity, progression, overload, initial values, reversibility, and diminishing returns); (b...

Blood lead levels and lung cancer mortality: An updated analysis of NHANES II and III.
https://doi.org/10.1002/cam4.3943
Cancer Medicine; Rhee J, Graubard BI et. al.

May 8th, 2021 - Previous analyses within the National Health and Nutrition Examination Survey (NHANES) II and III cycles suggested an association between blood lead levels (BLLs) and lung cancer mortality, although the evidence was limited by small case numbers. ...

see more →

News  7,279 results

Fast Five Quiz: Squamous Cell Non-Small Cell Lung Cancer
https://reference.medscape.com/viewarticle/928233

May 4th, 2021 - Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Non–small cell lung cancer (NSCLC), which accounts for 85% of all lung cancers, is divided histologically into adenocarcinoma, squamous cell carcinoma, and large cel...

Superior Survival With Sintilimab in Squamous NSCLC
https://www.medscape.com/viewarticle/950480

May 3rd, 2021 - Second-line treatment with sintilimab improved survival, when compared with docetaxel, in patients with advanced/metastatic squamous non–small cell lung cancer (sqNSCLC) in a phase 3 trial. Sintilimab improved both overall survival (OS) and progre...

Small Cell Lung Cancer Clinical Practice Guidelines (ESMO, 2021)
https://reference.medscape.com/viewarticle/950185

Apr 28th, 2021 - Updated guidelines on diagnosis, treatment, and follow-up of small cell lung cancer (SCLC) were published on April 9, 2021 by the European Society for Medical Oncology (ESMO) in the Annals of Oncology.[1] Diagnosis SCLC should be diagnosed accordi...

Tislelizumab Bests Docetaxel in NSCLC
https://www.medscape.com/viewarticle/949726

Apr 21st, 2021 - As second- or third-line therapy in patients with locally advanced non–small cell lung cancer (NSCLC), tislelizumab was well tolerated and prolonged overall survival (OS), compared with docetaxel in the phase 3 RATIONALE 303 study. The results wer...

Drug Duo Targeting ATR Enzyme Shrinks Small Cell Lung Cancer Tumors
https://www.medscape.com/viewarticle/949638

Apr 20th, 2021 - NEW YORK (Reuters Health) - Combining an ataxia telangiectasia and rad3-related (ATR) inhibitor with topoisomerase 1 (TOP1) yielded an objective response in more than a third of patients with small-cell lung cancer (SCLC) in a phase-2 proof-of-con...

see more →

Patient Education  103 results see all →